Please note that the copy function is not enabled for this field.
If you wish to
modify
existing outcomes, please copy and paste the current outcome text into the Update field.
LOGIN
CREATE ACCOUNT
LOGIN
CREATE ACCOUNT
MY TRIALS
REGISTER TRIAL
FAQs
HINTS AND TIPS
DEFINITIONS
Trial Review
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this
information for consumers
Download to PDF
Trial registered on ANZCTR
Registration number
ACTRN12615000221550
Ethics application status
Approved
Date submitted
10/02/2015
Date registered
9/03/2015
Date last updated
14/10/2016
Type of registration
Prospectively registered
Titles & IDs
Public title
Australasian Oncofertility Registry: uptake and utilisation of fertility preservation, reproductive health after cancer treatment, and future use and complications of assisted reproductive technologies in cancer survivors
Query!
Scientific title
Australasian Oncofertility Registry: uptake and utilisation of fertility preservation, reproductive health after cancer treatment, and future use and complications of assisted reproductive technologies in cancer survivors
Query!
Secondary ID [1]
286138
0
Nil Known
Query!
Universal Trial Number (UTN)
Query!
Trial acronym
AOFR
Query!
Linked study record
Query!
Health condition
Health condition(s) or problem(s) studied:
Fertility Preservation in cancer patients
294146
0
Query!
Sexual health in cancer patients
294147
0
Query!
Sexual dyfunction in cancer patients
294231
0
Query!
Assisted reproduction treatment (ART) in cancer patients
294232
0
Query!
Condition category
Condition code
Cancer
294466
294466
0
0
Query!
Any cancer
Query!
Reproductive Health and Childbirth
294688
294688
0
0
Query!
Fertility including in vitro fertilisation
Query!
Intervention/exposure
Study type
Observational
Query!
Patient registry
True
Query!
Target follow-up duration
20
Query!
Target follow-up type
Years
Query!
Description of intervention(s) / exposure
This project will establish the first web-based, multi-site Australasian Oncofertility Registry (AOFR) collecting data from cancer and fertility specialists. Outcomes generated from the study will provide meaningful translational data regarding uptake and utilisation of fertility preservation, future use and complications of assisted reproductive technologies as well as the potential for infertility following treatment for cancer survivors. The data from the registry and patient Medicare records will be used to perform a cost modeling health economics study.
The research study will be undertaken under five broad and interlinked themes. These themes include:
Themes 1: Awareness and referral for fertility preservation
Theme 2: Strategies, uptake, complications and quality of fertility preservation in cancer patients
Theme 3: Reproductive health following cancer treatment
Theme 4: Family planning and use of assisted reproductive technologies with pregnancy and birth outcomes
Theme 5: Health service utilisation and cost of fertility preservation programs for cancer patients in Australasia
Patients will be followed for a 20 year period to ensure that data on theme 3 and 4 can be captured.
Cancer survivors patients will be asked to consent to the research team collecting follow up data on patients fertility potential. For male patients this includes blood tests and semen analysis in year 1, 3 and 5 after cancer treatment. For female patients this includes blood tests and an ultrasound scan looking at follicle count annually.
Cancer patients that will be enrolled retrospectively from the previous two years - calendar years 2014-2016. Patient Medical Records will be accessed to undertake a retrospective review of eligible patient demographics, cancer details, treatment protocol, blood tests and scan results.
Query!
Intervention code [1]
291138
0
Not applicable
Query!
Comparator / control treatment
No control group to be studied
Query!
Control group
Uncontrolled
Query!
Outcomes
Primary outcome [1]
294251
0
Themes 1: Awareness and referral for fertility preservation
The outcome is assessed directly by data in the AOFR by descriptive statistics such as means, standard deviations, medians and inter quartile ranges for the variables and frequency distrubutions will be used to describe characteristics associated with a patients diagosis and referral for FP.
Query!
Assessment method [1]
294251
0
Query!
Timepoint [1]
294251
0
Data for this outcome will be captured at diagnosis. Data will be collected prospectively at diagnosis for all patients as well as patients that were unable to be captured prospectively at the time of diagnosis, the FUTuRE Fertility research group have decided to retrospectively go back two years to capture patients onto the Registry. This will enable the research team to capture greater numbers of patients diagnosed with cancer, accessing fertility preservation, onto the Registry.
The outcome is assessed by descriptive statistics such as means, standard deviations, medians and inter quartile ranges for the variables and frequency distributions will be used to describe characteristics associated with a patients diagnosis and referral for FP.
Query!
Primary outcome [2]
294329
0
Theme 2: Fertility preservation uptake
The outcome is assessed directly by data in the AOFR:
Semi-parametric regression will be used to assess the trends in uptkae of FP and stratified by age and gender. Univariable and multivariable logist regression models will be used to determine the independent predictors of the prevalence for fertility preservation over time throughout Australia.
Query!
Assessment method [2]
294329
0
Query!
Timepoint [2]
294329
0
Data for this outcome will be captured prospectively at a number of time points: 1. Diagnosis prior to treatment 2. Following cancer diagnosis in the first 5 years 3. At diagnosis of relapse prior to treatment 4. Following cancer treatment in the first 5 years.
Data will be collected prospectively at diagnosis for all patients
For cancer patient's enrolled retrospectively onto the Registry, their Medical Record will be accessed. Eligible patients to be enrolled retrospectively will be two years from date of diagnosis.
The outcome is assessed by: Semi-parametric regression will be used to assess the trends in uptake of FP and stratified by age and gender. Univariable and multivariable logist regression models will be used to determine the independent predictors of the prevalence for fertility preservation over time throughout Australia.
Query!
Primary outcome [3]
294330
0
Theme 3: Reproductive health following cancer treatment
The outcome is assessed directly by data in the AOFR:
Kaplain Meir survival analysis and Cox proportional regression models will be used to identify the factors associated with the time to return to normal reproductive function.
Query!
Assessment method [3]
294330
0
Query!
Timepoint [3]
294330
0
Data for this outcome will be captured annually from the end of treatment for the next 5 years.
The outcome is assessed by:
Kaplain Meir survival analysis and Cox proportional regression models will be used to identify the factors associated with the time to return to normal reproductive function.
Query!
Secondary outcome [1]
312875
0
Theme 4: Family planning and use of assisted reproductive technologies after cancer diagnosis
Method of assessment - Data collected on the registry ( natural or ART pregnancy, complication rates during ART, pregnancy, perinatal and neonatal outcomes).
The data is collected prospectively by the clinical team completing the registry form for a patient online or paper record. Patients consent to notes being reviewed for the purpose of ensuring a complete data set is collected and the notes will be reviewed if necessary by CRA staff.
Query!
Assessment method [1]
312875
0
Query!
Timepoint [1]
312875
0
Data will be collected prospectively annually for all cancer patients on the AOFR for 20 years
Query!
Secondary outcome [2]
313055
0
Theme 5: Health service utilisation and cost of fertility
Method of assessment - linkage to Medicare item numbers
Query!
Assessment method [2]
313055
0
Query!
Timepoint [2]
313055
0
Data for this outcome will be collected at the time of fertility preservation which may happen at diagnosis or in the 5 years following a cancer diagnosis
Query!
Eligibility
Key inclusion criteria
Update
Registry patient inclusion criteria
a. All patients (any cancer diagnosis) diagnosed with cancer
b. Cancer patients aged 13-45 who diagnosed with cancer
c. Cancer patients aged 0-12 years of age who are referred for fertility preservation only.
Those paediatric patients who are not referred for FP will not be eligible.
d. All retrospective patients within two years from diagnosis
Query!
Minimum age
No limit
Query!
Query!
Maximum age
45
Years
Query!
Query!
Sex
Both males and females
Query!
Can healthy volunteers participate?
No
Query!
Key exclusion criteria
Registry patient exclusion criteria
a. Non-cancer patients who are treated with gonadotoxic drugs will not be registered in phase 1.
b. Parents/siblings who undergo fertility preservation for a child/sibling.
c. Patients who do not consent to data being collected and reported.
d. Patients whose first language is not English when we cannot get an appropriate interpreter to provide consent for the study.
e. Patients who do not consent or assent to the registry
f. Patients who do not have cancer
g. Patients who are not of child bearing age
Query!
Study design
Purpose
Natural history
Query!
Duration
Longitudinal
Query!
Selection
Defined population
Query!
Timing
Both
Query!
Statistical methods / analysis
Descriptive statistics such as means, standard deviations, medians, inter-quartile ranges (for the continuous variables) and frequency distributions (for the categorical variables) will be used to describe characteristics associated with a cancer patient's diagnosis, acquisition of fertility preservation and ART.
New novel statistical techniques such as semi-parametric regression will be used to assess the trends in uptake of fertility preservation (after a cancer diagnosis) over the years which will be stratified by age and gender. Univariable and multivariable logistic regression models will be used to determine the independent predictors of the prevalence for fertility preservation and over the years in Australia.
Kaplan –Meir survival analysis and Cox proportional regression models will be used to identify the factors associated with time to return to normal reproductive function. Health economic strategies will be evaluated using a Markov decision model to conduct and compare the costs of FP strategies for cancer survivors
Query!
Recruitment
Recruitment status
Recruiting
Query!
Date of first participant enrolment
Anticipated
8/07/2015
Query!
Actual
8/07/2016
Query!
Date of last participant enrolment
Anticipated
Query!
Actual
Query!
Date of last data collection
Anticipated
Query!
Actual
Query!
Sample size
Target
2500
Query!
Accrual to date
Query!
Final
Query!
Recruitment in Australia
Recruitment state(s)
ACT,NSW,NT,QLD,SA,TAS,WA,VIC
Query!
Recruitment outside Australia
Country [1]
6641
0
New Zealand
Query!
State/province [1]
6641
0
Christchurch
Query!
Country [2]
6642
0
New Zealand
Query!
State/province [2]
6642
0
Auckland
Query!
Funding & Sponsors
Funding source category [1]
290708
0
Charities/Societies/Foundations
Query!
Name [1]
290708
0
Salesforce Australia Foundation
Query!
Address [1]
290708
0
Darling Park, 12/201 Sussex Street, Sydney NSW 2000
Query!
Country [1]
290708
0
Australia
Query!
Funding source category [2]
290709
0
Hospital
Query!
Name [2]
290709
0
Kids Cancer Centre, Sydey Children's Hospital
Query!
Address [2]
290709
0
High Street Randwick
Randwick
NSW
2031
Query!
Country [2]
290709
0
Australia
Query!
Funding source category [3]
290710
0
Charities/Societies/Foundations
Query!
Name [3]
290710
0
CanTeen Australia
Query!
Address [3]
290710
0
Level 11
130 Elizabeth Street,
Sydney
NSW
2000
Query!
Country [3]
290710
0
Australia
Query!
Funding source category [4]
290711
0
Charities/Societies/Foundations
Query!
Name [4]
290711
0
Fertility Society of Australia
Query!
Address [4]
290711
0
1119 Buckhurst Street
South Melbourne VIC 3205
Query!
Country [4]
290711
0
Australia
Query!
Primary sponsor type
University
Query!
Name
University of New South Wales
Query!
Address
Sydney NSW 2052, Australia
Query!
Country
Australia
Query!
Secondary sponsor category [1]
289400
0
None
Query!
Name [1]
289400
0
Query!
Address [1]
289400
0
Query!
Country [1]
289400
0
Query!
Ethics approval
Ethics application status
Approved
Query!
Ethics committee name [1]
292342
0
South Eastern Sydney Local Health District
Query!
Ethics committee address [1]
292342
0
Prince of Wales Hospital
High Street Randwick
Sydney
NSW
2031
Query!
Ethics committee country [1]
292342
0
Australia
Query!
Date submitted for ethics approval [1]
292342
0
Query!
Approval date [1]
292342
0
27/11/2014
Query!
Ethics approval number [1]
292342
0
14/245
Query!
Ethics committee name [2]
292349
0
Tasmanian Human Research Ethics Committee
Query!
Ethics committee address [2]
292349
0
Lauren Black
Executive Officer - Ethics
Office of Research Services
University of Tasmania
Private Bag 01
Hobart TAS 7001
Query!
Ethics committee country [2]
292349
0
Australia
Query!
Date submitted for ethics approval [2]
292349
0
Query!
Approval date [2]
292349
0
10/02/2015
Query!
Ethics approval number [2]
292349
0
H0014609
Query!
Ethics committee name [3]
292350
0
Royal Children's Hospital Melbourne Ethics
Query!
Ethics committee address [3]
292350
0
Royal Children's Hospital Melbourne
50 Flemington Road
Parkville
Victoria
3052
Query!
Ethics committee country [3]
292350
0
Australia
Query!
Date submitted for ethics approval [3]
292350
0
05/01/2015
Query!
Approval date [3]
292350
0
Query!
Ethics approval number [3]
292350
0
HREC/15/RCHM/1
Query!
Ethics committee name [4]
292351
0
ACT Health Human Research Ethics Committee
Query!
Ethics committee address [4]
292351
0
Ms August Marchesi
Building 10
Level 6
Canberra Hospital
1 Woden
ACT
2606
Query!
Ethics committee country [4]
292351
0
Australia
Query!
Date submitted for ethics approval [4]
292351
0
Query!
Approval date [4]
292351
0
12/01/2015
Query!
Ethics approval number [4]
292351
0
ETH.11.14.322
Query!
Ethics committee name [5]
292352
0
Princess Margaret Hospital
Query!
Ethics committee address [5]
292352
0
Ms Jenny Westgarth- Taylor
Level 1, CCRF, Princess Margaret Hospital
Roberts Road,
Subiaco
WA
6008
Query!
Ethics committee country [5]
292352
0
Query!
Date submitted for ethics approval [5]
292352
0
Query!
Approval date [5]
292352
0
05/01/2015
Query!
Ethics approval number [5]
292352
0
2015001EP
Query!
Ethics committee name [6]
292353
0
The Women's and Children's Hospital
Query!
Ethics committee address [6]
292353
0
72 King William Road
North Adelaide
South Australia
5006
Query!
Ethics committee country [6]
292353
0
Australia
Query!
Date submitted for ethics approval [6]
292353
0
05/01/2015
Query!
Approval date [6]
292353
0
Query!
Ethics approval number [6]
292353
0
Query!
Ethics committee name [7]
292355
0
The Lady Cilento Children's Hospital
Query!
Ethics committee address [7]
292355
0
501 Stanly Street
South Brisbane
Queensland 4101
Query!
Ethics committee country [7]
292355
0
Australia
Query!
Date submitted for ethics approval [7]
292355
0
05/01/2015
Query!
Approval date [7]
292355
0
Query!
Ethics approval number [7]
292355
0
Query!
Ethics committee name [8]
292356
0
Genea Fertility
Query!
Ethics committee address [8]
292356
0
Wendy Bradford, Level 2, 321 Kent Street Sydney NSW 2000
Query!
Ethics committee country [8]
292356
0
Australia
Query!
Date submitted for ethics approval [8]
292356
0
Query!
Approval date [8]
292356
0
17/12/2014
Query!
Ethics approval number [8]
292356
0
GEC0019
Query!
Summary
Brief summary
This study will establish the first web-based, multi-site Australasian Oncofertility Registry (AOFR) collecting data from cancer and fertility specialists. This study is for cancer patients who are diagnosed with cancer who are aged under 45 years old.
Who is it for?
You may be eligible to join this study if you are aged 13 years or above and have been diagnosed with cancer or aged 0-12 years diagnosed with cancer who have been referred for fertility preservation only.
Study Details
This study will collect data regarding uptake and utilisation of fertility preservation, future use and complications of assisted reproductive technologies as well as the potential for infertility following treatment for cancer survivors will be collected. Patients will be asked to consent to the research team collecting the results of fertility tests following cancer treatment. In males (semen analysis and fertility hormone blood tests in years 1,3,5). In females fertility hormone blood tests and ultrasound scans looking at the number of follicles in the ovaries.
The research study will be undertaken under five broad and interlinked themes. These themes include: Themes 1: Awareness and referral for fertility preservation Theme 2: Strategies, uptake, complications and quality of fertility preservation in cancer patients Theme 3: Reproductive health following cancer treatment Theme 4: Family planning and use of assisted reproductive technologies with pregnancy and birth outcomes
The data from the registry and patient Medicare records will be used to perform a cost modeling health economics study for theme.
Patients who consent to being part of the AOFR study wil be asked to supply data at diagnosis, end of treatment and then annually for 20 years.
Eligible patients or their parents/guardians/carers on behalf of the patient no longer being treated for their cancer at their cancer centre will be contacted retrospectively (2 years retrospectively from diagnosis) by the International FUTuRE Fertility Research Manager to explain the study and to determine whether eligible patients or parent/guardian/carer on behalf of their child would be interested in having their/their child's details stored on the registry. If a patient or parent/carer/guardian on behalf of the patient, is interested in having their/their child's Medical records reviewed in order to ascertain personal, cancer and fertility history then an information pack will be sent out to the patient/patient's family. The information pack will include study information details and patient consent forms.
Query!
Trial website
www.futurefertility.com.au
Query!
Trial related presentations / publications
Query!
Public notes
Query!
Attachments [1]
304
304
0
0
/AnzctrAttachments/367933-Future Fertility protocol 28_7_14.docx
Query!
Query!
Contacts
Principal investigator
Name
54790
0
Dr Antoinette Catherine Anazodo
Query!
Address
54790
0
Sydney Youth Cancer Service
Sydney Children's Hospital and Prince of Wales Hospital
High Street Randwick
Randwick
NSW
2031
Query!
Country
54790
0
Australia
Query!
Phone
54790
0
+61 (2) 93821733
Query!
Fax
54790
0
+61 (2) 93821789
Query!
Email
54790
0
[email protected]
Query!
Contact person for public queries
Name
54791
0
Mrs Brigitte Gerstl
Query!
Address
54791
0
National Project Manager
Kids Cancer Centre, Sydney Children's Hospital
High Street Randwick
Randwick
NSW
2031
Query!
Country
54791
0
Australia
Query!
Phone
54791
0
+61 (2) 9382 9287
Query!
Fax
54791
0
+61 (2) 93821789
Query!
Email
54791
0
[email protected]
Query!
Contact person for scientific queries
Name
54792
0
Dr Antoinette Catherine Anazodo
Query!
Address
54792
0
Sydney Youth Cancer Service
Sydney Children's Hospital and Prince of Wales Hospital
High Street Randwick
Randwick
NSW
2031
Query!
Country
54792
0
Australia
Query!
Phone
54792
0
+61 (2) 93821733
Query!
Fax
54792
0
+61 (2) 93821789
Query!
Email
54792
0
[email protected]
Query!
No information has been provided regarding IPD availability
What supporting documents are/will be available?
No Supporting Document Provided
Results publications and other study-related documents
Documents added manually
No documents have been uploaded by study researchers.
Documents added automatically
Source
Title
Year of Publication
DOI
Embase
A study protocol for the australasian oncofertility registry: Monitoring referral patterns and the uptake, quality, and complications of fertility preservation strategies in Australia and New Zealand.
2016
https://dx.doi.org/10.1089/jayao.2015.0062
N.B. These documents automatically identified may not have been verified by the study sponsor.
Download to PDF